ZA926021B - Immunostimulation. - Google Patents

Immunostimulation.

Info

Publication number: ZA926021B
Authority: ZA; South Africa
Prior art keywords: immunostimulation
Prior art date: 1991-08-13

Application number

ZA926021A

Inventor

Andrew Francis Geczy

Gregory John Russell-Jones

Stephen John Duncan Bell

David Albert Cooper

Original Assignee

Biotech Australia Pty Ltd

St Vincents Hosp Sydney

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-08-13

Filing date

1992-08-11

Publication date

1993-03-26

1992-08-11 Application filed by Biotech Australia Pty Ltd, St Vincents Hosp Sydney filed Critical Biotech Australia Pty Ltd

1993-03-26 Publication of ZA926021B publication Critical patent/ZA926021B/en

Links

230000003308 immunostimulating effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

ZA926021A 1991-08-13 1992-08-11 Immunostimulation. ZA926021B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AUPK772591		1991-08-13

Publications (1)

Publication Number	Publication Date
ZA926021B true ZA926021B (en)	1993-03-26

Family

ID=3775617

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA926021A ZA926021B (en)	1991-08-13	1992-08-11	Immunostimulation.

Country Status (10)

Country	Link
EP (1)	EP0598813A4 (en)
JP (1)	JPH07500819A (en)
CA (1)	CA2115424A1 (en)
CZ (1)	CZ28294A3 (en)
HU (2)	HUT70269A (en)
NZ (1)	NZ243929A (en)
OA (1)	OA09885A (en)
SK (1)	SK13494A3 (en)
WO (1)	WO1993003762A1 (en)
ZA (1)	ZA926021B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1210114A4 (en) *	1999-08-20	2004-01-02	Gen Hospital Corp	Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis
US8010189B2 (en)	2004-02-20	2011-08-30	Brainsgate Ltd.	SPG stimulation for treating complications of subarachnoid hemorrhage
US8055347B2 (en)	2005-08-19	2011-11-08	Brainsgate Ltd.	Stimulation for treating brain events and other conditions
US9233245B2 (en)	2004-02-20	2016-01-12	Brainsgate Ltd.	SPG stimulation
JP5731198B2 (en)	2007-09-27	2015-06-10	イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅＴｅｃｈｎｏｌｏｇｉｅｓＩｎｃ．	Use of liposomes in carriers containing a continuous hydrophobic phase for delivery of polynucleotides in vivo
WO2009146523A1 (en)	2008-06-05	2009-12-10	Immunovaccine Technologies Inc.	Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
BR112014007927B1 (en)	2011-10-06	2021-04-13	Immunovaccine Technologies Inc	LIPOSOME COMPOSITIONS UNDERSTANDING AN ADJUVANT AND USES OF THESE COMPOSITIONS AND USES OF THOSE COMPOSITIONS
EP2878335B1 (en)	2013-11-10	2018-01-03	Brainsgate Ltd.	Implant and delivery system for neural stimulator
EP3093043B1 (en)	2015-05-13	2018-11-14	Brainsgate Ltd.	Implant and delivery system for neural stimulator

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0109688A3 (en) *	1982-11-23	1986-12-03	The Wellcome Foundation Limited	Improved complexes, processes for obtaining them and formulations containing such complexes
US4459286A (en) *	1983-01-31	1984-07-10	Merck & Co., Inc.	Coupled H. influenzae type B vaccine
DE3483957D1 (en) *	1983-11-21	1991-02-21	Wellcome Found	COMPLEX, METHOD FOR THEIR PRODUCTION AND FORMULATIONS CONTAINING THE SAME.
NL8403195A (en) *	1984-10-19	1986-05-16	Nederlanden Staat	IMMUNOGENIC COMPLEXES AND VACCINES CONTAINING THESE.
CA1331355C (en) *	1986-04-21	1994-08-09	Bioenterprises Pty. Ltd	Immunopotentation
CA1340888C (en) *	1988-09-01	2000-02-01	Algis Anilionis	Vaccines and diagnostic assays for haemophilus influenzae
CH683101A5 (en) *	1990-09-18	1994-01-14	Biotech Australia Pty Ltd	New T-cell epitope(s) derived from the TraT protein of E.Coli

1992
- 1992-08-10 WO PCT/AU1992/000423 patent/WO1993003762A1/en not_active Application Discontinuation
- 1992-08-10 CZ CS94282A patent/CZ28294A3/en unknown
- 1992-08-10 EP EP9292917802A patent/EP0598813A4/en not_active Withdrawn
- 1992-08-10 CA CA002115424A patent/CA2115424A1/en not_active Abandoned
- 1992-08-10 HU HU9400233A patent/HUT70269A/en unknown
- 1992-08-10 SK SK134-94A patent/SK13494A3/en unknown
- 1992-08-10 JP JP5503956A patent/JPH07500819A/en active Pending
- 1992-08-11 ZA ZA926021A patent/ZA926021B/en unknown
- 1992-08-12 NZ NZ243929A patent/NZ243929A/en unknown
1994
- 1994-02-10 OA OA60472A patent/OA09885A/en unknown
- 1994-12-07 HU HU94P/P00050P patent/HU210605A9/en unknown

Also Published As

Publication number	Publication date
EP0598813A4 (en)	1994-09-14
JPH07500819A (en)	1995-01-26
CA2115424A1 (en)	1993-03-04
HU9400233D0 (en)	1994-05-30
EP0598813A1 (en)	1994-06-01
NZ243929A (en)	1994-12-22
HU210605A9 (en)	1995-05-29
SK13494A3 (en)	1994-09-07
HUT70269A (en)	1995-09-28
CZ28294A3 (en)	1994-05-18
OA09885A (en)	1994-09-15
WO1993003762A1 (en)	1993-03-04

Publication	Publication Date	Title
DE69107059D1 (en)	1995-03-09	Sigma-delta-modulator.
ZA92908B (en)	1993-08-09	Compounds.
AR244753A1 (en)	1993-11-30	Azo-colouring.
EP0597463A3 (en)	1996-11-06	Thermotherapiesonde.
EP0580285A3 (en)	1995-05-03	Auto-reclosers.
DE69104185D1 (en)	1994-10-27	Luftreservoir.
DE69112211D1 (en)	1995-09-21	Luftreinigungsvorrichtung.
DE69111595D1 (en)	1995-08-31	Squarylium- und crokonyliumfarbstoffe.
ZA929517B (en)	1993-07-12	Compounds.
DE59204008D1 (en)	1995-11-16	Trachealstent.
ZA926482B (en)	1993-03-08	Cyanophenylpyrroles.
DE69106281D1 (en)	1995-02-09	Phenanthrenderivat.
EP0572808A3 (en)	1995-05-31	Antiblocage-system.
ZA927792B (en)	1993-04-20	Anti-alpha6-integrin-antibodies.
ZA929590B (en)	1994-06-10	Diphenylsulphides.
DE69102644D1 (en)	1994-07-28	Demodulationsreferenzsignalquelle.
EP0598813A4 (en)	1994-09-14	Immunostimulation.
EP0576606A4 (en)	1994-11-23	Residual protease-iii.
DE69114491D1 (en)	1995-12-14	Olefincopolymere.
DE69110012D1 (en)	1995-06-29	Linienerkennungsverfahren.
EP0599191A3 (en)	1995-02-08	Speed-governor-circuit.
DE69205795D1 (en)	1995-12-07	Mesoprotheseunterlage.
EP0572573A4 (en)	1994-10-12	Thyroid-derived chondrocyte-stimulating factor.
ZA925185B (en)	1993-04-29	Dithianes.
DE69203865D1 (en)	1995-09-07	Thermo-transferdrucksystem.